GSK3B and breast cancer: Through this mechanism, PD-L1 can inhibit GSK3β-mediated phosphorylation, ubiquitination, and degradation of Snail1, thereby promoting EMT and the metastatic potential of breast cancer and cervical cancer (135, 136).